Evidence map›Paper›PMID 31513446›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2019

Pharmacological attenuation of group III/IV muscle afferents improves endurance performance when oxygen delivery to locomotor muscles is preserved.

Thomas J Hureau, Joshua C Weavil, Taylor S Thurston, Hsuan-Yu Wan, Jayson R Gifford, Jacob E Jessop, Michael J Buys, Russell S Richardson, Markus Amann

Abstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Obligatory neural feedback control of exercise cardiorespiratory function and performance.Journal of applied physiology (Bethesda, Md. : 1985) · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thomas J HureauDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
Joshua C WeavilGeriatric Research, Education, and Clinical Center, Salt Lake City Department of Veterans Affairs Medical Center, Salt Lake City, Utah.
Taylor S ThurstonDepartment of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah.
Hsuan-Yu WanDepartment of Anesthesiology, University of Utah, Salt Lake City, Utah.
Jayson R GiffordDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
Jacob E JessopDepartment of Anesthesiology, University of Utah, Salt Lake City, Utah.
Michael J BuysDepartment of Anesthesiology, University of Utah, Salt Lake City, Utah.
Russell S RichardsonDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.
Markus AmannDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah.

Funding

Role of Sensory Neurons in Human Cardiovascular DiseaseR01HL116579 · NHLBI · UNIVERSITY OF UTAH · PI AMANN, MARKUS · 2013 to 2021
$3.4M
NHLBI NIH HHS R01 HL116579
6 · The paper itself

Abstract

We sought to investigate the role of group III/IV muscle afferents in limiting endurance exercise performance, independently of their role in optimizing locomotor muscle O

Indexed as

Physical EnduranceAdultAfferent PathwaysBicyclingElectromyographyFemoral ArteryFentanylHumansInjections, SpinalMaleMuscle ContractionMuscle FatigueNerve Fibers, UnmyelinatedOxygenQuadriceps MuscleRegional Blood FlowFentanylOxygenblood flowcentral fatigueexercise limitationmetaboreflexneural feedback

Identifiers

PMID31513446
PMCPMC6879838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.